Health / Drugs / Cancer / Osteoporosis / BioPharma / Daily / Pharma / SYN / Top Story / biopharma nl / Boston / cancer / deals / F-star Therapeutics / life sciences M&A / osteoporosis / Radius Health / Tymlos

Biopharma firm Radius Health is going private in an $890M M&A deal

Posted on: Jun 23, 2022   |   Posted by: Care Mag

Biopharma firm Radius Health is going private in an $890M M&A deal

Two private equity firms have reached an $890 million deal to buy Radius Health, a company whose main asset is the commercialized osteoporosis drug Tymlos. In other M&A news...

Continue reading ...